Micell Technologies Overview
- Year Founded
-
1995
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Out of Business
Micell Technologies General Information
Description
Developer of drug delivery systems designed to treat cardiovascular diseases and transform patient outcomes. The company's systems use supercritical fluid technology that limits the duration of polymer exposure, optimize healing, more precisely and consistently control drug elution, enabling physicians to improve safety and clinical outcomes.
Contact Information
Website
www.micell.comCorporate Office
- P.O. Box 110025
- Durham, NC 27709
- United States
Corporate Office
- P.O. Box 110025
- Durham, NC 27709
- United States
Micell Technologies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Out of Business | 01-Apr-2021 | Completed | Out of Business | |||
| 10. Later Stage VC (Series E) | 14-Sep-2017 | Completed | Generating Revenue | |||
| 9. Later Stage VC (Series D2) | Completed | |||||
| 8. Later Stage VC (Series D1) | 30-Sep-2011 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series C) | 15-Apr-2011 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series B2) | 22-Sep-2009 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series B1) | 29-Jul-2009 | Completed | Generating Revenue | |||
| 4. Later Stage VC (Series A) | 05-Jul-2007 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 21-Feb-2005 | $2M | $3M | Completed | Generating Revenue | |
| 2. Grant | 01-Jan-2004 | $295K | $1M | Completed | Generating Revenue |
Micell Technologies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D2 | ||||||||
| Series D1 | ||||||||
| Series C | ||||||||
| Series B2 | ||||||||
| Series B1 | 2,921,349 | $0.004000 | $0.33 | $4.12 | $4.12 | 1x | $4.12 | 8.35% |
| Series A | 1,712,375 | $0.004000 | $4.12 | $4.12 | 1x | $4.12 | 4.89% |
Micell Technologies Comparisons
Industry
Financing
Details
Micell Technologies Competitors (4)
One of Micell Technologies’s 4 competitors is Ocular Therapeutix, a Formerly VC-backed company based in Bedford, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Ocular Therapeutix | Formerly VC-backed | Bedford, MA | ||||
| Beactica Therapeutics | Venture Capital-Backed | Uppsala, Sweden | ||||
| Humanetics Pharmaceuticals | Venture Capital-Backed | Excelsior, MN | ||||
| Cantex Pharmaceuticals | Formerly VC-backed | Weston, FL |
Micell Technologies Patents
Micell Technologies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3862032-A1 | Stents having biodegradable layers | Inactive | 07-Feb-2020 | ||
| JP-2021122748-A | Stents having biodegradable layers | Pending | 07-Feb-2020 | ||
| EP-3740323-A1 | Transfer ring | Inactive | 17-Jan-2018 | ||
| US-20210052781-A1 | Transfer ring | Inactive | 17-Jan-2018 | ||
| WO-2019143687-A1 | Transfer ring | Inactive | 17-Jan-2018 | A61L29/08 |
Micell Technologies Signals
Micell Technologies FAQs
-
When was Micell Technologies founded?
Micell Technologies was founded in 1995.
-
Where is Micell Technologies headquartered?
Micell Technologies is headquartered in Durham, NC.
-
What is the size of Micell Technologies?
Micell Technologies has 14 total employees.
-
What industry is Micell Technologies in?
Micell Technologies’s primary industry is Drug Delivery.
-
Is Micell Technologies a private or public company?
Micell Technologies is a Private company.
-
What is Micell Technologies’s current revenue?
The current revenue for Micell Technologies is .
-
How much funding has Micell Technologies raised over time?
Micell Technologies has raised $145M.
-
Who are Micell Technologies’s competitors?
Ocular Therapeutix, Beactica Therapeutics, Humanetics Pharmaceuticals, and Cantex Pharmaceuticals are competitors of Micell Technologies.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process